Open Access

Preliminary results of a non-invasive method to measure tumor size and distribution in vivo

  • Authors:
    • Shu‑Ling Fu
    • Chien‑An Chen
    • Ling‑Chien Hung
    • Moon‑Sing Lee
    • Wen‑Yen Chiou
    • Hon‑Yi Lin
    • Yu‑Chieh Su
    • Ching‑Chih Lee
    • Shih‑Kai Hung
  • View Affiliations

  • Published online on: October 19, 2016     https://doi.org/10.3892/etm.2016.3819
  • Pages: 3614-3620
  • Copyright: © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Molecular imaging of reporter gene expression in cancer cells can provide rapid, sensitive and non-invasive monitoring of tumor behavior. The aim of the present study was to establish a non‑invasive method to measure tumor size and distribution in vivo. Briefly, H-Ras-transformed cells were stably transfected with a plasmid containing the luciferase gene (Luc), designated as Ras/Luc. Ras/Luc cells were injected into the back or tail vein of nude BALB/cAnN-Foxn1nu/CrlNarl mice (age, 6‑8 weeks). Mice were subsequently administered D‑luciferin via intra‑peritoneal injection, prior to image acquisition. Photons emitted from the mice were detected via an imaging system. Tumor size and distribution in vivo were quantified as photons/second. Andrographolide has demonstrated radiosensitization in previous in vitro and in vivo studies. In the present study, the potential effects of andrographolide cancer metastasis were investigated further, using an imaging system. Preliminary results of andrographolide combined with radiation indicated the inhibition of cancer metastasis. The present mechanistic study of andrographolide‑mediated effects demonstrated that activated extracellular signal regulated kinase protein and H2O2 production levels were significantly increased by andrographolide. In summary, the present study established a non‑invasive method to measure tumor size and distribution in vivo and indicated that andrographolide may be a potential therapeutic strategy in cancer therapy.
View Figures
View References

Related Articles

Journal Cover

December-2016
Volume 12 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fu SL, Chen CA, Hung LC, Lee MS, Chiou WY, Lin HY, Su YC, Lee CC and Hung SK: Preliminary results of a non-invasive method to measure tumor size and distribution in vivo. Exp Ther Med 12: 3614-3620, 2016
APA
Fu, S., Chen, C., Hung, L., Lee, M., Chiou, W., Lin, H. ... Hung, S. (2016). Preliminary results of a non-invasive method to measure tumor size and distribution in vivo. Experimental and Therapeutic Medicine, 12, 3614-3620. https://doi.org/10.3892/etm.2016.3819
MLA
Fu, S., Chen, C., Hung, L., Lee, M., Chiou, W., Lin, H., Su, Y., Lee, C., Hung, S."Preliminary results of a non-invasive method to measure tumor size and distribution in vivo". Experimental and Therapeutic Medicine 12.6 (2016): 3614-3620.
Chicago
Fu, S., Chen, C., Hung, L., Lee, M., Chiou, W., Lin, H., Su, Y., Lee, C., Hung, S."Preliminary results of a non-invasive method to measure tumor size and distribution in vivo". Experimental and Therapeutic Medicine 12, no. 6 (2016): 3614-3620. https://doi.org/10.3892/etm.2016.3819